PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 22, 2026Current Medicinal Chemistry3 citations

Recent Advances in Flavonoids and Chronic Disease: Mechanisms, Therapeutic Applications, and Future Directions

View Full Paper
YZYueyan ZhaoHLHanxiang LiuYLYijia Li

Key Points

  • This review aims to summarize the recent advances in flavonoid research related to chronic diseases.
  • Review of current literature on flavonoids and their effects on chronic disease mechanisms.
  • Analysis of signaling pathways influenced by flavonoids, including NF-κB, Nrf2, and PI3K/Akt.
  • Discussion on the challenges of bioavailability and metabolic variability of flavonoids.
  • Flavonoids exhibit antioxidant, anti-inflammatory, neuroprotective, and anticancer properties.
  • They modulate key signaling pathways and improve chemotherapy sensitivity.
  • Flavonoids show potential in improving cardiovascular health and metabolic regulation.

Abstract

Abstract: Flavonoids are a diverse class of polyphenolic secondary metabolites found in fruits, vegetables, tea, and medicinal plants, known for their antioxidant, anti-inflammatory, neuroprotective, and anticancer properties. This review summarizes recent advances in flavonoid research, focusing on their roles in aging, neuroprotection, cardiovascular health, metabolic regulation, inflammation, and cancer therapy. Flavonoids exert their effects by modulating key signaling pathways, such as NF-κB, Nrf2, PI3K/Akt, MAPK, and Wnt/β-catenin. They mitigate oxidative stress, enhance mitochondrial function, regulate autophagy, and modulate immune responses, offering potential therapeutic benefits against chronic diseases. Additionally, flavonoids improve chemotherapy sensitivity, inhibit tumor metastasis, and suppress angiogenesis. However, their poor bioavailability and individual metabolic variability present challenges for clinical translation. Future research should focus on nanotechnology-based delivery systems, personalized medicine strategies, and large-scale clinical trials to optimize flavonoid efficacy and facilitate their application in functional foods and pharmaceuticals.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhao et al. (2026) studied this question.

synapsesocial.com/papers/69bf3955c7b3c90b18b43fc2https://doi.org/10.2174/0109298673399264251209104743
Ask AI
Helpful
Bookmark
Share
View Full Paper